Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Nanjing Shijiang Medicine Technology Co. Ltd. is managing 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 5 actions are distributed among 5 distinct examiners, which indicates that no individual examiner is handling multiple cases for the company simultaneously. This distribution may lead to independent review processes for each application.
The prosecution efforts span 4 distinct art units, suggesting that the pending matters cover a variety of technical sub-specialties within the biotechnology field. SHIAO, REI TSANG is the busiest examiner for the portfolio, with 1 pending office action. This workload of 1 pending office action is consistent across the distinct examiners involved with the company's current applications. Because the 5 pending office actions are spread across 4 distinct art units, the portfolio shows technical diversity within its primary technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, REI TSANG | 1 | 79.8% | -33.6% |
| SEAMAN, D MARGARET M | 1 | 76.5% | +8.0% |
| BAUER, BRIANNA LEE | 1 | 100.0% | +0.0% |
| SHAMEEM, GOLAM M | 1 | 86.7% | +16.0% |
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 65.8% | +51.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684802 | APPLICATION OF BENZISOQUINOLINE DIKETONE COMPOUND IN TREATMENT OF TUMOR | SHAMEEM, GOLAM M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684789 | APPLICATION OF BENZANILIDE COMPOUND IN TUMOR TREATMENT | SEAMAN, D MARGARET M | — |
| 18685925 | APPLICATION OF HYDRAZIDE COMPOUND IN TUMOR TREATMENT | BAUER, BRIANNA LEE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684802 | APPLICATION OF BENZISOQUINOLINE DIKETONE COMPOUND IN TREATMENT OF TUMOR | SHAMEEM, GOLAM M | — |
| 18268236 | BENZENE RING COMPOUND AND USE THEREOF | VISHNYAKOVA, ELENA VLADIMIROVNA | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1626 | 1 |
| 1621 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18686461 | APPLICATION OF TETRACYCLINE COMPOUND IN TREATMENT OF TUMOR | SHIAO, REI TSANG | — | §103 | Final Rejection | — | Pending | Apr 22, 2024 |
| 18684789 | APPLICATION OF BENZANILIDE COMPOUND IN TUMOR TREATMENT | SEAMAN, D MARGARET M | 1625 | §102§112 | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18685925 | APPLICATION OF HYDRAZIDE COMPOUND IN TUMOR TREATMENT | BAUER, BRIANNA LEE | 1626 | §102§103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18684802 | APPLICATION OF BENZISOQUINOLINE DIKETONE COMPOUND IN TREATMENT OF TUMOR | SHAMEEM, GOLAM M | 1621 | §112 | Non-Final OA | — | Pending | Feb 19, 2024 |
| 18268236 | BENZENE RING COMPOUND AND USE THEREOF | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103DP | Final Rejection | — | Pending | Jun 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial